GME, AMC, RIOT and ZS among premarket gainers
Nabriva Therapeutics NBRV+51%as its Nabriva antibiotic meets primary endpoint.Pieris Pharmaceuticals (PIRS) +20%.Protagenic Therapeutics (PTIX) +11%.
Nabriva Therapeutics NBRV+51%as its Nabriva antibiotic meets primary endpoint.Pieris Pharmaceuticals (PIRS) +20%.Protagenic Therapeutics (PTIX) +11%.
